new cases every year
+100% in 20 years
1/3 of the people with melanoma
are under 50 years old
deaths per year
most frequent cancer
Switzerland has the highest skin cancer incidence in Europe,
2nd ranking world wide
Survival rate at 5 years
when detected late
Chance of recovery with early detection
Dermoscopy is a new method broadly used by dermatologists since the beginning of this century that allows to look deeper into the skin. The dermatologist uses a dermoscope, a device equipped with a magnifying lens and lighting system enabling to see more precisely moles and pigmented lesions.
The DermoSafe mole check is done by digital dermoscopy (DermoClic) and via the DermoView web platform enabling specialists to evaluate moles remotely and to share it with the patient and dermatologists.
Dermoscopy enables much better performance
distinguishing malignant and benign lesions
Visit a medical center or partner practice equipped with DermoSafe's solution and services.
DermoSafe's telemedicine exam is simple and non invasive. Dermoscopic pictures of one or several moles are taken at the medical center or partner practice with the DermoClic device. These pictures are visualised by a dermoscopy specialist (a technical method in dermatology used to visualise skin lesions with great precision) in less than 72 hours.
It is not a diagnostic tool, but a method that aims at identifying your suspicious moles which might result in being problematic, at the earliest stage possible. Proven digital dermoscopy specialists assess the mole(s) through the captured pictures. If melanoma or other skin cancer is suspected, the patient will then be referred to a partner dermatologist who will be in charge of providing the final diagnosis through a laboratory exam.
DermoSafe enables you to get a quick and efficient medical opinion about the actual state of one or several moles on your body, in less than 72 hours. Should a melanoma be detected at an early stage (by a dermatologist), healing chances are then more than 95% of the cases !
DermoSafe's service does not allow itself to give a final diagnosis on suspect lesions because the confirmed diagnosis can only be done by biopsy or excision (surgical act) by a dermatologist.